Skip to main content
Erschienen in:

01.08.2021

Stakeholder Perspectives on Colonoscopy Navigation and Colorectal Cancer Screening Inequities

verfasst von: Deeonna E. Farr, Venice E. Haynes, Cheryl A. Armstead, Heather M. Brandt

Erschienen in: Journal of Cancer Education | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Black adults complete colonoscopies at lower rates than other groups despite increased colorectal cancer risk. Patient navigation represents a strategy to address the varied factors that influence colonoscopy completion, but few reports describe how navigation reduces racial disparities in colorectal cancer screening rates. The purpose of this study was to understand how a statewide colonoscopy navigation program addressed the challenges faced by low-income Black adults attempting to complete screening colonoscopy. A qualitative case study analysis was conducted at a participating clinical site of a statewide colonoscopy navigation program. Clinical observations, document reviews, and semi-structured interviews were conducted with patients, patient navigators, and clinical staff. Patient participants were recruited to ensure maximum variation related to gender and colonoscopy completion. Thematic coding allowed researchers to examine experiences, perceptions, and emotions related to patient navigation. In total, 31 interviews were completed between October 2014 and February 2015. Patients and patient navigators reported logistical, psychosocial, and knowledge-related barriers to colonoscopy completion. Clinical staff reports focused mostly on logistical barriers. Benefits of patient navigation also varied by participant type with clinical staff revealing positive effects on the clinic's relationships with referring specialty practices. Patient navigators address barriers that are important to patients, but often unseen by clinical staff/providers. New information about the benefits different stakeholders derive from this strategy was revealed. Together these findings provide insight into the processes associated with this strategy and novel information about the appeal of patient navigation to various stakeholders.
Literatur
2.
Zurück zum Zitat Center for Disease Control and Prevention (CDC) (2015) BRFSS prevalance and trends data [online]. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA Center for Disease Control and Prevention (CDC) (2015) BRFSS prevalance and trends data [online]. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA
7.
Zurück zum Zitat Paskett ED, Harrop J, Wells KJ (2011) Patient navigation: an update on the state of the science. CA Cancer J Clin 61:237–249CrossRef Paskett ED, Harrop J, Wells KJ (2011) Patient navigation: an update on the state of the science. CA Cancer J Clin 61:237–249CrossRef
14.
Zurück zum Zitat Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM, American College of Gastroenterology (2009) American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol 104:739–750CrossRef Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM, American College of Gastroenterology (2009) American College of Gastroenterology guidelines for colorectal cancer screening 2008. Am J Gastroenterol 104:739–750CrossRef
16.
Zurück zum Zitat Patton MQ (2002) Qualitative research and evaluation methods, 3rd edn. Sage Publications, Thousand Oaks, Calif Patton MQ (2002) Qualitative research and evaluation methods, 3rd edn. Sage Publications, Thousand Oaks, Calif
17.
Zurück zum Zitat QSR International (2012) NVivo qualitative data analysis software verison 10. QSR International Pty Ltd. QSR International (2012) NVivo qualitative data analysis software verison 10. QSR International Pty Ltd.
19.
Zurück zum Zitat Honeycutt S, Green R, Ballard D, Hermstad A, Brueder A, Haardörfer R, Yam J, Arriola KJ (2013) Evaluation of a patient navigation program to promote colorectal cancer screening in rural Georgia, USA: colonoscopy screening program evaluation. Cancer 119:3059–3066. https://doi.org/10.1002/cncr.28033CrossRefPubMed Honeycutt S, Green R, Ballard D, Hermstad A, Brueder A, Haardörfer R, Yam J, Arriola KJ (2013) Evaluation of a patient navigation program to promote colorectal cancer screening in rural Georgia, USA: colonoscopy screening program evaluation. Cancer 119:3059–3066. https://​doi.​org/​10.​1002/​cncr.​28033CrossRefPubMed
20.
Zurück zum Zitat Jean-Pierre P, Hendren S, Fiscella K, Loader S, Rousseau S, Schwartzbauer B, Sanders M, Carroll J, Epstein R (2010) Understanding the processes of patient navigation to reduce disparities in cancer care: perspectives of trained navigators from the field. J Cancer Educ 26:111–120. https://doi.org/10.1007/s13187-010-0122-xCrossRef Jean-Pierre P, Hendren S, Fiscella K, Loader S, Rousseau S, Schwartzbauer B, Sanders M, Carroll J, Epstein R (2010) Understanding the processes of patient navigation to reduce disparities in cancer care: perspectives of trained navigators from the field. J Cancer Educ 26:111–120. https://​doi.​org/​10.​1007/​s13187-010-0122-xCrossRef
Metadaten
Titel
Stakeholder Perspectives on Colonoscopy Navigation and Colorectal Cancer Screening Inequities
verfasst von
Deeonna E. Farr
Venice E. Haynes
Cheryl A. Armstead
Heather M. Brandt
Publikationsdatum
01.08.2021
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 4/2021
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-019-01684-2

Neu im Fachgebiet Onkologie

KI erlaubt neue Einsichten in die Krebsprognose

Forschende sind in komplexen Real-World-Daten des Westdeutschen Tumorzentrums auf bisher weniger beachtete Zusammenhänge von bestimmten Risikomarkern mit der Prognose gestoßen. Möglich gemacht hat’s ein Verfahren namens „erklärbare KI“, mit dem sich hunderte Tumor- und Patientenmerkmale gleichzeitig betrachten lassen.

Körperlich fitte Krebskranke leben länger

Krebspatienten, auch und vor allem solche in fortgeschrittenen Stadien, profitieren offenbar von guter körperlicher Verfassung. Hohe Muskelkraft und kardiorespiratorische Fitness sind laut Ergebnissen einer Metaanalyse mit geringerer Mortalität assoziiert.

Kein (großer) Schutz vor Kolorektalkarzinom-Rezidiven durch ASS

Die erste Phase-3-Studie zum Nutzen von ASS in der adjuvanten Therapie des kolorektalen Karzinoms ist negativ verlaufen. Das abschließende Urteil über eine Sekundärprävention mit ASS ist trotzdem noch nicht gefallen.

Frühe CLL-Therapie: BTK-Hemmer verlängert EFS und PFS, aber nicht OS

Auch nach sechs Jahren ergibt sich kein Überlebensvorteil einer Therapie mit dem BTK-Hemmer Ibrutinib für Menschen mit frühem CLL-Stadium und erhöhtem Progressionsrisiko. Die Progressionsrate wird mit der Behandlung jedoch um über 80% gesenkt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.